024 Pharma, Inc. — key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2016)

$1.1M

Net Income/Loss (FY2016)

$621.0K

Total Assets (FY2016)

$839.8K

Total Equity (FY2016)

$759.0K

Source: 024 Pharma, Inc. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.